HEADER ELECTRON TRANSPORT 17-DEC-90 3TRX TITLE HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REDUCED RECOMBINANT TITLE 2 HUMAN THIOREDOXIN IN SOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: THIOREDOXIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS ELECTRON TRANSPORT EXPDTA SOLUTION NMR AUTHOR J.D.FORMAN-KAY,G.M.CLORE,A.M.GRONENBORN REVDAT 4 16-MAR-22 3TRX 1 REMARK SEQADV REVDAT 3 24-FEB-09 3TRX 1 VERSN REVDAT 2 15-JAN-93 3TRX 1 HEADER COMPND REVDAT 1 15-JAN-92 3TRX 0 JRNL AUTH J.D.FORMAN-KAY,G.M.CLORE,P.T.WINGFIELD,A.M.GRONENBORN JRNL TITL HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REDUCED JRNL TITL 2 RECOMBINANT HUMAN THIOREDOXIN IN SOLUTION. JRNL REF BIOCHEMISTRY V. 30 2685 1991 JRNL REFN ISSN 0006-2960 JRNL PMID 2001356 JRNL DOI 10.1021/BI00224A017 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.D.FORMAN-KAY,A.M.GRONENBORN,L.E.KAY,P.T.WINGFIELD, REMARK 1 AUTH 2 G.M.CLORE REMARK 1 TITL STUDIES ON THE SOLUTION CONFORMATION OF HUMAN THIOREDOXIN REMARK 1 TITL 2 USING HETERONUCLEAR 15N-1H NUCLEAR MAGNETIC RESONANCE REMARK 1 TITL 3 SPECTROSCOPY REMARK 1 REF BIOCHEMISTRY V. 29 1566 1990 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.D.FORMAN-KAY,G.M.CLORE,P.C.DRISCOLL,P.WINGFIELD, REMARK 1 AUTH 2 F.M.RICHARDS,A.M.GRONENBORN REMARK 1 TITL A PROTON NUCLEAR MAGNETIC RESONANCE ASSIGNMENT AND SECONDARY REMARK 1 TITL 2 STRUCTURE DETERMINATION OF RECOMBINANT HUMAN THIOREDOXIN REMARK 1 REF BIOCHEMISTRY V. 28 7088 1989 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 STRUCTURES DETERMINED BY THE HYBRID METRIC REMARK 3 MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING REMARK 3 METHOD OF M. NILGES, G. M. CLORE, AND A. M. GRONENBORN REMARK 3 (FEBS LETT. 229, 317 (1988)). THE STRUCTURES ARE BASED REMARK 3 ON 1983 INTERPROTON DISTANCE RESTRAINTS DERIVED FROM NOE REMARK 3 MEASUREMENTS; 52 HYDROGEN-BONDING DISTANCE RESTRAINTS FOR REMARK 3 26 HYDROGEN-BONDS IDENTIFIED ON THE BASIS OF THE NOE AND REMARK 3 AMIDE PROTON EXCHANGE DATA, AS WELL AS THE INITIAL REMARK 3 STRUCTURE CALCULATIONS; AND 98 PHI AND 71 PSI BACKBONE REMARK 3 TORSION ANGLE RESTRAINTS AND 72 CHI1 SIDE-CHAIN TORSION REMARK 3 ANGLE RESTRAINTS DERIVED FROM COUPLING CONSTANTS AND NOE REMARK 3 DATA. REMARK 3 REMARK 3 A TOTAL OF 33 STRUCTURES WERE CALCULATED. THIS STRUCTURE REMARK 3 REPRESENTS THE MINIMIZED AVERAGE STRUCTURE. THIS IS REMARK 3 OBTAINED BY AVERAGING THE COORDINATES OF THE INDIVIDUAL REMARK 3 STRUCTURES AND SUBJECTING THE RESULTING COORDINATES TO REMARK 3 RESTRAINED MINIMIZATION. THE ENTIRE SET OF 33 STRUCTURES REMARK 3 CAN BE FOUND IN PDB ENTRY 4TRX. REMARK 3 REMARK 3 THE LAST COLUMN IN THIS COORDINATE FILE REPRESENTS THE REMARK 3 ATOMIC RMS DEVIATION OF THE INDIVIDUAL STRUCTURES ABOUT REMARK 3 THE MEAN COORDINATE POSITIONS. REMARK 4 REMARK 4 3TRX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179177. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 31 CG TRP A 31 CD2 -0.106 REMARK 500 HIS A 43 CG HIS A 43 ND1 -0.115 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 31 CG - CD1 - NE1 ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP A 31 CD1 - NE1 - CE2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 31 NE1 - CE2 - CZ2 ANGL. DEV. = 8.6 DEGREES REMARK 500 TRP A 31 NE1 - CE2 - CD2 ANGL. DEV. = -6.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 6 -19.36 -143.93 REMARK 500 LYS A 21 160.40 -45.37 REMARK 500 PRO A 40 0.91 -62.13 REMARK 500 LYS A 48 -71.28 -59.08 REMARK 500 VAL A 59 17.60 -68.77 REMARK 500 LYS A 72 22.71 -145.56 REMARK 500 CYS A 73 126.42 -176.26 REMARK 500 LYS A 82 11.14 57.37 REMARK 500 GLU A 95 -18.39 -46.46 REMARK 500 GLU A 98 -72.77 -50.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4TRX RELATED DB: PDB DBREF 3TRX A 2 105 UNP P10599 THIO_HUMAN 1 104 SEQADV 3TRX THR A 74 UNP P10599 MET 73 CONFLICT SEQRES 1 A 105 MET VAL LYS GLN ILE GLU SER LYS THR ALA PHE GLN GLU SEQRES 2 A 105 ALA LEU ASP ALA ALA GLY ASP LYS LEU VAL VAL VAL ASP SEQRES 3 A 105 PHE SER ALA THR TRP CYS GLY PRO CYS LYS MET ILE LYS SEQRES 4 A 105 PRO PHE PHE HIS SER LEU SER GLU LYS TYR SER ASN VAL SEQRES 5 A 105 ILE PHE LEU GLU VAL ASP VAL ASP ASP CYS GLN ASP VAL SEQRES 6 A 105 ALA SER GLU CYS GLU VAL LYS CYS THR PRO THR PHE GLN SEQRES 7 A 105 PHE PHE LYS LYS GLY GLN LYS VAL GLY GLU PHE SER GLY SEQRES 8 A 105 ALA ASN LYS GLU LYS LEU GLU ALA THR ILE ASN GLU LEU SEQRES 9 A 105 VAL HELIX 1 1 SER A 7 ALA A 18 1 12 HELIX 2 2 CYS A 35 MET A 37 5 3 HELIX 3 3 ILE A 38 HIS A 43 1 6 HELIX 4 4 SER A 44 TYR A 49 1 6 HELIX 5 5 CYS A 62 SER A 67 1 6 HELIX 6 6 LYS A 94 VAL A 105 1 12 SHEET 1 A 5 LYS A 3 GLN A 4 0 SHEET 2 A 5 ILE A 53 ASP A 58 1 O PHE A 54 N LYS A 3 SHEET 3 A 5 VAL A 23 SER A 28 1 O VAL A 24 N LEU A 55 SHEET 4 A 5 THR A 76 LYS A 81 -1 O THR A 76 N PHE A 27 SHEET 5 A 5 GLN A 84 SER A 90 -1 O GLN A 84 N LYS A 81 CISPEP 1 THR A 74 PRO A 75 0 -0.90 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000